Rathbones Group PLC Verona Pharma PLC Transaction History
Rathbones Group PLC
- $19.7 Billion
- Q4 2024
A detailed history of Rathbones Group PLC transactions in Verona Pharma PLC stock. As of the latest transaction made, Rathbones Group PLC holds 10,218 shares of VRNA stock, worth $670,300. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,218
Previous 11,901
14.14%
Holding current value
$670,300
Previous $342,000
38.6%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding VRNA
# of Institutions
218Shares Held
70.5MCall Options Held
1.4MPut Options Held
299K-
Perceptive Advisors LLC New York, NY6.39MShares$419 Million9.9% of portfolio
-
Nea Management Company, LLC Timonium, MD5.58MShares$366 Million18.53% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA3.38MShares$222 Million9.42% of portfolio
-
Eventide Asset Management, LLC Boston, MA3.13MShares$205 Million2.79% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx3.13MShares$205 Million2.81% of portfolio
About Verona Pharma plc
- Ticker VRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,954,200
- Market Cap $4B
- Description
- Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodi...